Nicholas J. Simon III

Nicholas J. Simon III has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Pharmasset Inc, ARYx Therapeutics, Inc. and Neorx Corp. We count 28 filings; the first trade dates from 9 January 2007 and the latest from 9 June 2010.

On the open market, the record shows 4 purchases worth €11.2M and 8 sales worth €3.4M. On balance, insiders were net buyers of €7.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.

The median purchase comes to €2.6M.

The newest entry dates from 11 June 2010: a share grant, in Neorx Corp. The last purchase on record was published on 17 November 2008, which is 6,550 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.